3 employees
Corisma develops a catheter implanted circulatory assist device designed to treat patients suffering from advanced heart failure.
2018
$27M
from 1 investors over 1 rounds
CoRISMA Cardiovascular raised $27M on August 30, 2021
Investors: Grand Pharmaceutical (China) Co., Ltd.